Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc. (ticker: CPMV) is an OTC-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of CPMV's SEC filings surfaces 27 active risk signals, including 26 late-filing signals, and 1 auditor-change signal. CPMV reported no tagged revenue in revenue and -$688K for the period ending 2025-12-31, with operating cash flow of -$111K. Cash and equivalents stood at $4K (down 96.9% year-over-year). Total assets of $20K are exceeded by total liabilities of $7.50M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.